Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Initial Study of a MOTHER-DAUGHTER SIDE-BRANCH ACCESS™ DES System (FIH Feasibility Study)

NCT: NCT07649798 · ACTIVE_NOT_RECRUITING

NCT IDNCT07649798
StatusACTIVE_NOT_RECRUITING
Start Date2025-09-16
Completion2028-11-19
SponsorAdvanced Bifurcation Systems Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This first in human feasibility study is designed to evaluate the feasibility MD-SBA DES in subjects undergoing percutaneous coronary intervention (PCI) to treat bifurcation lesions.

Frequently Asked Questions

What is Initial Study of a MOTHER-DAUGHTER SIDE-BRANCH ACCESS™ DES System (FIH Feasibility Study)?

Initial Study of a MOTHER-DAUGHTER SIDE-BRANCH ACCESS™ DES System (FIH Feasibility Study) is a clinical trial registered under NCT07649798. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07649798?

The current status of NCT07649798 (Initial Study of a MOTHER-DAUGHTER SIDE-BRANCH ACCESS™ DES System (FIH Feasibility Study)) is: ACTIVE_NOT_RECRUITING.

When did Initial Study of a MOTHER-DAUGHTER SIDE-BRANCH ACCESS™ DES System (FIH Feasibility Study) start?

Initial Study of a MOTHER-DAUGHTER SIDE-BRANCH ACCESS™ DES System (FIH Feasibility Study) started on 2025-09-16.

Related Devices

PMA P210014Coronary drug-eluting stentAdvanced Bifurcation Systems, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑